NEW YORK (GenomeWeb News) – Agilent Technologies and WiCell said today they are teaming up to offer comparative genomic hybridization plus single nucleotide polymorphism microarray analysis services using the Agilent SurePrint G3 Human Genome CGH+SNP Microarray.

The microarray detects copy number changes by both SNP and CGH while simultaneously delivering copy-neutral change information such as loss or absence of heterozygosity, the companies said. They added that the assay maintains the high-resolution quality achieved with CGH-only microarrays.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.